Pharmacist-Led Audit and Feedback

Uses

How it works

Preparation

Highlighted claims

• Intervention-arm general practitioners receive a multi-component strategy aimed at reducing benzodiazepine, PPI, and antipsychotic prescribing in patients aged 65 or older. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
• Monthly personalised feedback reports show older-patient prescribing rates for long-term benzodiazepines, PPIs without valid indication, and antipsychotics in dementia. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
• High-prescribing general practitioners are invited to 25–35 minute pharmacist-led face-to-face sessions. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
• The intervention includes monthly clinical messages with evidence-based deprescribing strategies and guidance. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
• The intervention includes a self-paced online training module covering safe prescribing and deprescribing recommendations for the three target drug classes. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study